Clinical Trials for Alkermes

Explore 8 clinical trials worldwide

Showing 1-8 of 8 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Alkermes

Clinical Trials (8)

NCT06843590
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
PHASE2Recruiting
96 participants
Started: May 22, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor40 locations
NCT06767683
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
PHASE2/PHASE3Recruiting
256 participants
Started: Jan 27, 2025 · Completed: Jun 30, 2028
3 conditions1 sponsor44 locations
NCT06555783
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2
PHASE2Active, not recruiting
80 participants
Started: Jul 26, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor47 locations
NCT05495984
Neuroplasticity in Maternal Opioid Use Disorder (OUD)
NARecruiting
15 participants
Started: Jan 1, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05303064
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
PHASE3Recruiting
220 participants
Started: Jun 30, 2022 · Completed: Sep 30, 2026
2 conditions1 sponsor47 locations
NCT05028062
Naltrexone in AUD Reward Drinkers
PHASE4Recruiting
60 participants
Started: Mar 7, 2022 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT04987229
Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects
PHASE3Enrolling by invitation
236 participants
Started: Oct 22, 2021 · Completed: Sep 30, 2027
2 conditions1 sponsor40 locations
NCT01246765
National Pregnancy Registry for Psychiatric Medications
N/ARecruiting
5,000 participants
Started: Nov 30, 2008 · Completed: Dec 31, 2033
2 conditions8 sponsors1 location